Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management SYC Tong, JS Davis, E Eichenberger, TL Holland, VG Fowler Jr Clinical microbiology reviews 28 (3), 603-661, 2015 | 5612 | 2015 |
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 I Thevarajan, THO Nguyen, M Koutsakos, J Druce, L Caly, ... Nature medicine 26 (4), 453-455, 2020 | 1282 | 2020 |
A minimal common outcome measure set for COVID-19 clinical research JC Marshall, S Murthy, J Diaz, NK Adhikari, DC Angus, YM Arabi, K Baillie, ... The lancet infectious diseases 20 (8), e192-e197, 2020 | 1157 | 2020 |
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1135 | 2021 |
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 521 | 2021 |
Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network CD Ericsson, C Hatz, K Leder, S Tong, L Weld, KC Kain, A Wilder-Smith, ... Clinical infectious diseases 43 (9), 1185, 2006 | 474 | 2006 |
The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma AC Bowen, A Mahe, RJ Hay, RM Andrews, AC Steer, SYC Tong, ... PloS one 10 (8), e0136789, 2015 | 314 | 2015 |
Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: the non-pigmented Staphylococcus argenteus sp. nov. and the non-human primate … SYC Tong, F Schaumburg, MJ Ellington, J Corander, B Pichon, ... International journal of systematic and evolutionary microbiology 65 (Pt_1 …, 2015 | 248 | 2015 |
Sequence element enrichment analysis to determine the genetic basis of bacterial phenotypes CJ Lees JA, Vehkala M, Välimäki N, Harris SR, Chewapreecha C, Croucher NJ ... Nature Communications 7, 12797, 2016 | 225 | 2016 |
Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a … SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ... Jama 323 (6), 527-537, 2020 | 214 | 2020 |
Gene exchange drives the ecological success of a multi-host bacterial pathogen EJ Richardson, R Bacigalupe, EM Harrison, LA Weinert, S Lycett, ... Nature ecology & evolution 2 (9), 1468-1478, 2018 | 214 | 2018 |
Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 204 | 2021 |
A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin DC Holt, MTG Holden, SYC Tong, S Castillo-Ramirez, L Clarke, MA Quail, ... Genome biology and evolution 3, 881, 2011 | 192 | 2011 |
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial JS Davis, A Sud, MVN O'Sullivan, JO Robinson, PE Ferguson, H Foo, ... Clinical Infectious Diseases 62 (2), 173-180, 2016 | 190 | 2016 |
Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics MR Davies, L McIntyre, A Mutreja, JA Lacey, JA Lees, RJ Towers, ... Nature genetics 51 (6), 1035-1043, 2019 | 187 | 2019 |
Microbiological applications of high-resolution melting analysis SYC Tong, PM Giffard Journal of clinical microbiology 50 (11), 3418-3421, 2012 | 185 | 2012 |
Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities S Quiñones-Parra, E Grant, L Loh, THO Nguyen, KA Campbell, SYC Tong, ... Proceedings of the National Academy of Sciences 111 (3), 1049-1054, 2014 | 179 | 2014 |
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 151 | 2021 |
Genomic insights to control the emergence of vancomycin-resistant enterococci BP Howden, KE Holt, MMC Lam, T Seemann, S Ballard, GW Coombs, ... MBio 4 (4), 10.1128/mbio. 00412-13, 2013 | 151 | 2013 |
Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? SYC Tong, LF Chen, VG Fowler Seminars in immunopathology 34, 185-200, 2012 | 150 | 2012 |